OBJECTIVE - To evaluate the impact of dosage frequency on the complian
ce of patients who receive their medicines from community pharmacies.
RESEARCH DESIGN AND METHODS - Each month, patients received a supply o
f their medication in a Medication Event Monitoring Systems container,
which registered each opening of the package. Ar the end of the study
the patients received a short questionnaire. The subjects were 91 dia
betic patients using oral antidiabetic agents. Patients taking insulin
and those who were unable to collect their medicines from the pharmac
y were excluded from the study. Compliance was defined as the percenta
ge of doses taken during the observation period. Another parameter use
d was compliance with the prescribed regimen, defined as the percentag
e of days in which the number of tablets were taken as prescribed. As
a last parameter. compliance with the prescribed dose intervals was us
ed. RESULTS - Compliance is influenced by the frequency of doses. The
compliance for this group of patients is 74.8%, with an average of 79%
in the case of a dose once daily and 38% in the case of a dose three
times daily The predominant type of noncompliance in all groups was do
se omissions. However, more than one-third of the patients used more d
oses than prescribed. Overconsumption is a frequently made mistake by
patients on a one-dose daily schedule. CONCLUSIONS - The reduction of
dose frequency may decrease total noncompliance, but at the same time,
it increases the risk of overconsumption. Reducing the frequency does
not automatically result in a better therapeutic schedule. The choice
of once or twice daily should depend on the therapeutic range of the
drug.